Active Shortage

TEGRETOL SUSPENSION

NOVARTIS PHARMACEUTICALS CANADA INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of TEGRETOL SUSPENSION in Canada?

Yes. TEGRETOL SUSPENSION 100MG has an active shortage reported to Health Canada (last updated November 4, 2026).

Why is TEGRETOL SUSPENSION not available?

The reason the manufacturer reported: Demand increase for the drug.

When will TEGRETOL SUSPENSION be available again?

The manufacturer's estimated resolution date is November 24, 2026. This is an estimate and can change; follow this page to get an email when the status changes.

Can I still get this?Possibly — same-ingredient product records found

StatusActive Shortage

Same-ingredient products on file6 products · 1 same form & route

Expected resolution~12 days remaining (estimate)

Affected strength100MG

Report last updated2026-11-04

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Closest Matches

TARO-CARBAMAZEPINE

TARO PHARMACEUTICALS INC

100MG · DIN 02367394

Same strengthSame dosage formSame routeNo current shortage

Compare these two →

Other Products

TARO-CARBAMAZEPINE CHEWABLE TABLETS

TARO PHARMACEUTICALS INC

100MG · DIN 02244403

Same strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEGRETOL CR

NOVARTIS PHARMACEUTICALS CANADA INC

400MG · DIN 00755583

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

TEGRETOL

NOVARTIS PHARMACEUTICALS CANADA INC

200MG · DIN 00010405

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

SANDOZ-CARBAMAZEPINE CR

SANDOZ CANADA INCORPORATED

200MG · DIN 02261839

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

MINT-CARBAMAZEPINE

MINT PHARMACEUTICALS INC

200MG · DIN 02541238

Different strengthDifferent dosage formSame routeNo current shortage

Compare these two →

What this means

Does this mean my pharmacy is out of stock?

Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.

What should I do?

Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.

Have you checked a pharmacy recently?

No community reports yet — be the first to share what you found.

Community reports are not verified by a pharmacy and may reflect a small sample size. This is not a guarantee of current stock.

DIN

02194333

Strength

100MG

Dosage Form

SUSPENSION

Route

ORAL

Active Ingredient

CARBAMAZEPINE

See all CARBAMAZEPINE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage Timeline

Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.

Active/anticipated Resolved

Shortage History

2026-11-04

Active Shortage

Demand increase for the drug.

Other Products from NOVARTIS PHARMACEUTICALS CANADA INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

10MG · DIN 02339528

2.5MG · DIN 02369257

5MG · DIN 02339501

7.5MG · DIN 02450267

2MG · DIN 02425645

3MG · DIN 02425653